MARTINA KERSCHEN: Open Payments
NPI 1912359936 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 18 payments from 8 companies in 2025. Trend: 2023 $111 · 2024 $407 · 2025 $416
Food & beverage: $321Education: $95
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $191 |
| Viatris Specialty LLC | 1 | $42 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| Grifols USA, LLC | 1 | $32 |
| Insmed, Inc. | 2 | $32 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Pulmonx Corporation | 1 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $26 |
Products named: DUPIXENT, YUPELRI, KEYTRUDA, Prolastin-C Liquid, Arikayce, CHARTIS CATHETER, OPSUMIT, TRELEGY ELLIPTA.
Industry payments across MI — which companies pay providers there.
